Bhubaneswar: The Drugs Controller General of India (DCGI) on Thursday granted conditional market approval for COVID-19 vaccines, Covishield and Covaxin, for use in adult population with certain conditions.
The vaccines, however, will not be available at medical stores. Hospitals and clinics can purchase the vaccines.
The approval has been granted under the New Drugs and Clinical Trials Rules, 2019.
The price of these vaccines of Serum Institute of India and Bharat Biotech is likely to be capped at Rs 275 per dose plus an additional service charge of Rs 150, the PTI reported quoting official sources.
Both the vaccines are currently only authorised for emergency use in India. While Covaxin is priced at Rs 1,200 per dose, Covishield costs Rs 780 at private facilities.
Mumbai: Bollywood’s 'Mr Perfectionist' Aamir Khan has been contemplating quitting the industry for quite some…
Balasore: Two minor girls reportedly drowned while trying to collect miniature boats from a pond…
Ahmedabad: The Central government’s resolve to clamp down on illegal drug trafficking in the country resulted…
Bhubaneswar: The School of Hotel Management, faculty of hospitality and tourism management of Siksha ‘O’…
New Delhi: Clouds of uncertainty continue to hover over the Champions Trophy, which is scheduled to…
Bhubaneswar: Odisha Chief Minister Mohan Charan Majhi on Friday laid foundation stone for development projects…
Mumbai: Abbas-Mustan’s 1993 film ‘Baazigar’ had played a major role in shaping Shah Rukh Khan’s…
Cuttack: Odisha gave their supporters at Barabati Stadium some really nervous moments here on Friday…